| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cefepime neurotoxicity despite renal adjusted dosing. | Scand J Infect Dis | 2011 | 0.84 |
| 2 | Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature. | Rare Tumors | 2009 | 0.82 |
| 3 | Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. | Urol Oncol | 2011 | 0.81 |
| 4 | Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy. | Clin Genitourin Cancer | 2012 | 0.78 |
| 5 | A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors. | Invest New Drugs | 2013 | 0.77 |
| 6 | Images in clinical medicine: Congenital melanocytic nevus. | N Engl J Med | 2013 | 0.75 |